- Home
- EOS vs TLRY Comparison
EOS vs TLRY Comparison
Compare EOS & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOS
- TLRY
- Stock Information
- Founded
- EOS 2005
- TLRY N/A
- Country
- EOS United States
- TLRY Canada
- Employees
- EOS N/A
- TLRY N/A
- Industry
- EOS Trusts Except Educational Religious and Charitable
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- EOS Finance
- TLRY Health Care
- Exchange
- EOS Nasdaq
- TLRY Nasdaq
- Market Cap
- EOS 1.3B
- TLRY 1.3B
- IPO Year
- EOS N/A
- TLRY 2018
- Fundamental
- Price
- EOS $24.01
- TLRY $1.17
- Analyst Decision
- EOS
- TLRY Hold
- Analyst Count
- EOS 0
- TLRY 3
- Target Price
- EOS N/A
- TLRY $1.88
- AVG Volume (30 Days)
- EOS 84.1K
- TLRY 43.5M
- Earning Date
- EOS 01-01-0001
- TLRY 01-10-2025
- Dividend Yield
- EOS 6.80%
- TLRY N/A
- EPS Growth
- EOS N/A
- TLRY N/A
- EPS
- EOS N/A
- TLRY N/A
- Revenue
- EOS N/A
- TLRY $829,216,000.00
- Revenue This Year
- EOS N/A
- TLRY $16.98
- Revenue Next Year
- EOS N/A
- TLRY $5.96
- P/E Ratio
- EOS N/A
- TLRY N/A
- Revenue Growth
- EOS N/A
- TLRY 18.38
- 52 Week Low
- EOS $15.62
- TLRY $1.14
- 52 Week High
- EOS $20.63
- TLRY $2.97
- Technical
- Relative Strength Index (RSI)
- EOS 53.22
- TLRY 38.95
- Support Level
- EOS $23.35
- TLRY $1.15
- Resistance Level
- EOS $24.31
- TLRY $1.23
- Average True Range (ATR)
- EOS 0.32
- TLRY 0.08
- MACD
- EOS -0.05
- TLRY -0.02
- Stochastic Oscillator
- EOS 68.54
- TLRY 5.56
About EOS Eaton Vance Enhance Equity Income Fund II
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. It invests in a portfolio of large and mid-cap securities in the sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.